Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1 Breast 1

Conditions

Carcinoma, Non-Small-Cell Lung 2709 Lung Neoplasms 2267 Small Cell Lung Carcinoma 452 Breast Neoplasms 394 Neoplasms 348 Colorectal Neoplasms 245 Ovarian Neoplasms 208 Pancreatic Neoplasms 196 Melanoma 196 Prostatic Neoplasms 187 Adenocarcinoma of Lung 184 Neoplasm Metastasis 177 Head and Neck Neoplasms 175 Mesothelioma, Malignant 152 Esophageal Neoplasms 144 Carcinoma, Renal Cell 142 Stomach Neoplasms 141 Colonic Neoplasms 138 Urinary Bladder Neoplasms 124 Mesothelioma 121 Squamous Cell Carcinoma of Head and Neck 115 Uterine Cervical Neoplasms 97 Sarcoma 86 Brain Neoplasms 86 Kidney Neoplasms 82 Carcinoma, Hepatocellular 71 Liver Neoplasms 68 Adenocarcinoma, Bronchiolo-Alveolar 68 Rectal Neoplasms 64 Pleural Effusion, Malignant 64

Interventions

atezolizumab 1 alectinib 1 Vemurafenib 1 Ado-Trastuzumab Emtansine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Genomic Instability × Thoracic × Clear all

NCT02314481 2026-05-04

DARWINII

University College, London

Phase 2 Completed

Carcinoma, Non-Small-Cell Lung, Genomic Instability

Data powered by HemOnc (CC BY 4.0) Colophon ⚡